253 related articles for article (PubMed ID: 28965549)
1. Mild stimulation for in vitro fertilization.
Nargund G; Datta AK; Fauser BCJM
Fertil Steril; 2017 Oct; 108(4):558-567. PubMed ID: 28965549
[TBL] [Abstract][Full Text] [Related]
2. Ovarian stimulation in ART - Unwinding pressing issues.
Zech NH; Zech M; Baldauf S; Comploj G; Murtinger M; Spitzer D; Hradecký L; Ajayi R; Schuff M; Zech H
Minerva Ginecol; 2015 Apr; 67(2):127-47. PubMed ID: 25668422
[TBL] [Abstract][Full Text] [Related]
3. Minimal stimulation IVF vs conventional IVF: a randomized controlled trial.
Zhang JJ; Merhi Z; Yang M; Bodri D; Chavez-Badiola A; Repping S; van Wely M
Am J Obstet Gynecol; 2016 Jan; 214(1):96.e1-8. PubMed ID: 26259908
[TBL] [Abstract][Full Text] [Related]
4. The myths surrounding mild stimulation in vitro fertilization (IVF).
Orvieto R; Vanni VS; Gleicher N
Reprod Biol Endocrinol; 2017 Jun; 15(1):48. PubMed ID: 28645286
[TBL] [Abstract][Full Text] [Related]
5. [CHALLENGING THE OPTIMAL NUMBER OF RETRIEVED OOCYTES AND ITS IMPACT ON PREGNANCY AND LIVE BIRTH RATES IN IVF/ICSI CYCLES].
Blais I; Lahav-Baratz S; Koifman M; Wiener-Megnazi Z; Auslender R; Dirnfeld M
Harefuah; 2015 Jun; 154(6):350-5, 406. PubMed ID: 26281076
[TBL] [Abstract][Full Text] [Related]
6. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
[TBL] [Abstract][Full Text] [Related]
7. PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome.
Yovich JL; Alsbjerg B; Conceicao JL; Hinchliffe PM; Keane KN
Drug Des Devel Ther; 2016; 10():2561-73. PubMed ID: 27563236
[TBL] [Abstract][Full Text] [Related]
8. In vitro fertilization treatments with the use of clomiphene citrate or letrozole.
Haas J; Casper RF
Fertil Steril; 2017 Oct; 108(4):568-571. PubMed ID: 28965550
[TBL] [Abstract][Full Text] [Related]
9. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
[TBL] [Abstract][Full Text] [Related]
10. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.
Zarek SM; Muasher SJ
Fertil Steril; 2011 Jun; 95(8):2449-55. PubMed ID: 21550037
[TBL] [Abstract][Full Text] [Related]
11. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
[TBL] [Abstract][Full Text] [Related]
12. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
Das M; Son WY; Buckett W; Tulandi T; Holzer H
Reprod Biomed Online; 2014 Nov; 29(5):545-51. PubMed ID: 25262236
[TBL] [Abstract][Full Text] [Related]
13. [IVF in a modified natural cycle].
Bos AM; Pelinck MJ; Dumoulin JC; Arts EG; van Echten-Arends J; Simons AH
Ned Tijdschr Geneeskd; 2010; 154(45):A2519. PubMed ID: 21118595
[TBL] [Abstract][Full Text] [Related]
14. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
Orvieto R; Nahum R; Zohav E; Liberty G; Anteby EY; Meltcer S
Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
[TBL] [Abstract][Full Text] [Related]
15. Modified natural cycle in in vitro fertilization.
Ho JR; Paulson RJ
Fertil Steril; 2017 Oct; 108(4):572-576. PubMed ID: 28965551
[TBL] [Abstract][Full Text] [Related]
16. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
[TBL] [Abstract][Full Text] [Related]
17. Ovarian hyperstimulation syndrome prevention strategies: in vitro maturation.
Huang JY; Chian RC; Tan SL
Semin Reprod Med; 2010 Nov; 28(6):519-31. PubMed ID: 21157982
[TBL] [Abstract][Full Text] [Related]
18. The prevention of ovarian hyperstimulation syndrome.
Corbett S; Shmorgun D; Claman P; ;
J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
[TBL] [Abstract][Full Text] [Related]
19. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
Zhu YM; Gao HJ; He RH; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
